HOME >> BIOLOGY >> NEWS
Experimental Biology 2007: Today's Research, Tomorrow's Health, April 28-May 2

d novel therapies based on molecules of the innate immune system.

The American Society for Pharmacology and Experimental Therapeutics offers symposia on cannabinoids (a chemical compound in cannabis or marijuana), endocannabinoids (a marijuana-like substance) and pain associated with inflammation, stress, psychiatric disorders, neurodegenerative disorders, and other disorders; the future of pharmacogenomics and its clinical applications; nanotechnology in disease therapeutics; osteoporosis and bone research (a symposium subtitled "no time to be bad to the bone"); toxicology of nanomaterials (including effects on the skin and lungs); the ways in which nicotine modulates adolescent brain plasticity, interacts with other drugs during sensitive developmental periods, and, when used along with alcohol by a woman during pregnancy, alters drug responsiveness in offspring; an examination of why children, adolescents and adults respond differently to antidepressants; studies of how perinatal stress, such as maternal separation, affects drug response and propensity to abuse drugs as an adult; and cardiovascular gene therapy.

The American Physiological Society program includes 16 societal or distinguished lectures and a Physiology Infocus session that focuses on novel technologies in physiology and medicine, such as advances in forensic medicine, new approaches in imaging, and the use of experimental evolution (selecting for particular physiological attributes in large laboratory populations) as a tool of physiological analysis. Other workshops include human subject research ethics and the challenge of presenting basic research in an anti-science, anti-evolution and anti-education era. Among topics for symposia or individual research presentations are: cancer and hypoxia (starving tumors of oxygen) ; pharmacogenomics of estrogen and cardiovascular disease; roles of intestinal epithelia and bacteria in inflammatory disease; and the potential benefits of
'"/>

Contact: Sylvia Wrobel
ebpress@bellsouth.net
770-270-0989
Federation of American Societies for Experimental Biology
25-Feb-2007


Page: 1 2 3 4 5

Related biology news :

1. 38 minority scientists receive travel fellowships to Experimental Biology 2007 in D.C.
2. Experimental Biology 2007 meets in Washington, D.C., April 28-May 2
3. Experimental cancer drugs counter muscle deterioration seen in muscular dystrophy
4. Experimental RNA-based drug kills prostate cancer cells effectively and safely
5. Experimental vaccine protects nonhuman primates when given after exposure to Marburg virus
6. Undergrads compete for American Physiological Society Bruce awards at Experimental Biology
7. Experimental drug reverses key cognitive deficits, pathology in Alzheimers
8. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
9. Experimental evolution of yeast in the lab may illuminate early events in speciation
10. Advancing the biomedical frontier: Experimental Biology 2006
11. Experimental Biology 2006 meets in San Francisco April 1-5

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... , ... AMRI, a global contract research, development and manufacturing ... and quality of life, will now be offering its impurity solutions as a ... requirements for all new drug products, including the finalization of ICH M7 earlier ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased ... of over 5.5 million people each year. Especially those living in larger cities are ... - based in one of the most pollution-affected countries globally - decided to take ...
Breaking Biology Technology:
Cached News: